Inhaling to mitigate exhaled bioaerosols

Area of Science:

• Respiratory Medicine
• Aerosol Science
• Infectious Disease Transmission

Background:

• Humans naturally exhale small droplets called exhaled bioaerosols.
• These bioaerosols can carry airborne pathogens, contributing to the spread of diseases like influenza and tuberculosis.
• Individual differences exist in the quantity of bioaerosols produced during normal breathing.

Purpose of the Study:

• To investigate if altering lung airway surface properties with an inhaled aerosol can reduce exhaled bioaerosol droplets.
• To explore a simple method for mitigating airborne infectious disease spread.
• To identify if targeting 'high-producer' individuals can be an effective strategy.

Main Methods:

• Administering nebulized isotonic saline to human subjects identified as 'high-producers' of exhaled bioaerosols.
• Measuring the reduction in exhaled bioaerosol particle count.
• Conducting in vitro and in vivo experiments using saline and surfactants.
• Investigating the physical properties of airway-lining fluid, particularly surface tension.

Main Results:

• Nebulized isotonic saline significantly reduced exhaled bioaerosol particles by 72.10 +/- 8.19% in high-producers.
• The reduction in particle expulsion lasted for up to 6 hours.
• Experiments suggest the mechanism involves modifying the physical properties, specifically surface tension, of the airway-lining fluid.

Conclusions:

• Targeted inhalation of nebulized saline can effectively decrease exhaled bioaerosol production in high-exhaling individuals.
• This intervention offers a potential non-pathogen-specific method to reduce airborne disease transmission.
• Modifying airway surface tension is a key factor in reducing exhaled bioaerosols.